Akums Drugs & Pharma

511.35
+16.40
(3.31%)
Market Cap
8,048.34 Cr
EPS
-0.28
PE Ratio
54.48
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
1,175.90
52 Week low
483.00
PB Ratio
2.75
Debt to Equity
0.83
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy100.00 %
100.00 %
Hold0.0 %
0.0 %
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,669.30 4,00,520.99 34.13 49,887.20 12.06 9,648 13.77 37.74
5,978.30 1,58,705.08 76.14 8,184.00 0.89 1,600 64.53 51.57
1,479.70 1,19,502.65 23.70 26,520.70 14.17 4,155 47.38 51.15
3,095.95 1,04,781.02 56.64 10,785.70 11.59 1,656 13.54 45.77
1,170.95 97,705.34 18.09 28,905.40 12.36 5,578 1.69 30.83
2,348.45 96,889.27 47.77 10,615.60 19.57 1,942 -16.38 39.42
899.65 90,525.84 19.78 19,831.50 13.82 3,831 29.92 36.77
1,977.50 90,213.07 31.46 20,141.50 19.94 1,936 38.82 38.83
1,121.25 65,122.38 18.72 29,559.20 17.55 3,169 -10.04 42.81
29,429.65 62,535.95 47.37 6,097.20 10.80 1,201 16.01 61.56
Growth Rate
Revenue Growth
12.48 %
Net Income Growth
-99.18 %
Cash Flow Change
182.09 %
ROE
-99.19 %
ROCE
-97.66 %
EBITDA Margin (Avg.)
-63.65 %

Quarterly Financial Results

Quarterly Financials
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
978
1,188
1,093
955
1,026
1,050
1,030
Expenses
1,095
1,057
989
941
891
912
889
EBITDA
-117
131
103
14
135
138
141
Operating Profit %
-13 %
11 %
9 %
0 %
13 %
12 %
12 %
Depreciation
30
30
32
34
34
35
45
Interest
12
14
12
12
13
12
5
Profit Before Tax
-159
87
59
-33
88
92
91
Tax
29
54
-136
7
26
25
25
Net Profit
-187
33
195
-40
61
67
66
EPS in ₹
-13.16
2.22
13.21
-2.89
4.21
4.37
4.26

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
Total Assets
2,078
2,192
3,069
3,267
3,516
Fixed Assets
645
834
1,021
1,097
1,191
Current Assets
1,250
1,157
1,864
1,879
1,941
Capital Work in Progress
57
87
31
103
195
Investments
6
19
0
0
0
Other Assets
1,371
1,252
2,017
2,066
2,130
Total Liabilities
2,078
2,192
3,069
3,267
3,516
Current Liabilities
730
580
1,272
1,266
1,211
Non Current Liabilities
627
725
1,172
1,278
1,585
Total Equity
721
887
625
723
721
Reserve & Surplus
721
884
608
689
681
Share Capital
1
1
14
29
29

Cash Flow

Cash Flow
2015
2016
2020
2021
2022
2023
2024
Net Cash Flow
-11
4
71
-70
33
-4
59
Investing Activities
-150
-123
-190
-109
-235
-305
-331
Operating Activities
72
89
28
135
32
177
498
Financing Activities
66
37
233
-95
236
125
-108

Share Holding

% Holding
Feb 2024
Aug 2024
Sept 2024
Dec 2024
Promoter
84.91 %
75.26 %
75.26 %
75.26 %
FIIs
0.00 %
5.32 %
7.34 %
6.36 %
DIIs
0.00 %
7.60 %
7.52 %
7.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
4.43 %
2.11 %
3.33 %
Others
15.09 %
7.38 %
7.77 %
8.05 %
No of Share Holders
8
1,38,205
57,531
68,410

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication
5 days ago
Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Grant Of Patent
6 days ago
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
6 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
9 days ago
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
9 days ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
9 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Feb 07, 2025, 18:49
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 07, 2025, 15:57
Statement Of Deviation.
Feb 07, 2025, 15:55
Integrated Filing (Financial)
Feb 07, 2025, 15:53
Announcement under Regulation 30 (LODR)-Investor Presentation
Feb 07, 2025, 15:48
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Feb 07, 2025, 15:46
Un-Audited Financial Results For The Quarter And Nine Months Ended December 31 2024.
Feb 07, 2025, 15:42
Board Meeting Outcome for Outcome Of Board Meeting Held On 06Th February 2025
Feb 06, 2025, 17:58
Announcement under Regulation 30 (LODR)-Cessation
Feb 05, 2025, 15:00
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 03, 2025, 11:43
Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December 2024.
Feb 01, 2025, 15:17
Update On Income Tax Search
Jan 23, 2025, 18:27
Income Tax Search
Jan 22, 2025, 10:57
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 11, 2025, 12:16
Change Of Name Of RTA
Jan 02, 2025, 14:23
Closure of Trading Window
Dec 28, 2024, 12:28

Technical Indicators